BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18176996)

  • 21. Urticaria due to etanercept in a patient with psoriatic arthritis.
    Borrás-Blasco J; Gracia-Perez A; Rosique-Robles JD; Nuñez-Cornejo C; Casterá MD; Abad FJ
    South Med J; 2009 Mar; 102(3):304-5. PubMed ID: 19204628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case definition of psoriatic arthritis.
    Taylor WJ; Fellow DE; Helliwell PS
    Lancet; 2000 Dec; 356(9247):2095; author reply 2096. PubMed ID: 11145512
    [No Abstract]   [Full Text] [Related]  

  • 23. From wheels to feet: a dramatic response of severe chronic psoriatic arthritis to etanercept.
    ElKayam O; Yaron M; Caspi D
    Ann Rheum Dis; 2000 Oct; 59(10):839. PubMed ID: 11203155
    [No Abstract]   [Full Text] [Related]  

  • 24. Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature.
    Taban M; Dupps WJ; Mandell B; Perez VL
    Ocul Immunol Inflamm; 2006 Jun; 14(3):145-50. PubMed ID: 16766397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid response of nail psoriasis to etanercept.
    Rallis E; Stavropoulou E; Rigopoulos D; Verros C
    J Rheumatol; 2008 Mar; 35(3):544-5. PubMed ID: 18322982
    [No Abstract]   [Full Text] [Related]  

  • 27. Urticaria pigmentosa after treatment with TNF antagonists: a case report.
    Leloup P; Daviet V; Chiffoleau A; Dréno B
    Arch Dermatol; 2011 Dec; 147(12):1459-60. PubMed ID: 22184778
    [No Abstract]   [Full Text] [Related]  

  • 28. Psoriatic arthritis in a military aviator.
    Sulit DJ; Clarke JE
    Aviat Space Environ Med; 2005 Jul; 76(7):684-8. PubMed ID: 16018354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnosis and management of psoriatic arthritis in a professional football player presenting with a knee effusion: a case report.
    Brophy RH; MacKenzie CR; Gamradt SC; Barnes RP; Rodeo SA; Warren RF
    Clin J Sport Med; 2008 Jul; 18(4):369-71. PubMed ID: 18614892
    [No Abstract]   [Full Text] [Related]  

  • 30. Rapid growth of Merkel cell carcinoma during etanercept treatment of psoriatic arthritis: cause or coincidence?
    de Giorgi V; Benemei S; Grazzini M; Lotti T; Geppetti P
    Acta Derm Venereol; 2011 May; 91(3):354-5. PubMed ID: 21369689
    [No Abstract]   [Full Text] [Related]  

  • 31. Transient and slight thrombocytopaenia induced by etanercept during treatment of psoriatic arthritis.
    Stinco G; Piccirillo F; Patrone P
    Acta Derm Venereol; 2008; 88(3):281-2. PubMed ID: 18480934
    [No Abstract]   [Full Text] [Related]  

  • 32. Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.
    Moustou AE; Stratigos AJ; Vergou T; Gregoriou S; Georgala S; Danopoulou I
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):968-9. PubMed ID: 19207660
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of etanercept treatment on ultraviolet B-induced inflammation, cell cycle regulation and DNA damage.
    Gambichler T; Tigges C; Dith A; Skrygan M; Scola N; Altmeyer P; Kreuter A
    Br J Dermatol; 2011 Jan; 164(1):110-5. PubMed ID: 20973771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etanercept in infants: suberythrodermic, recalcitrant psoriasis in a 22 month-old child successfully treated with etanercept.
    Fabrizi G; Guerriero C; Pagliarello C
    Eur J Dermatol; 2007; 17(3):245. PubMed ID: 17478389
    [No Abstract]   [Full Text] [Related]  

  • 35. Etanercept for toxic epidermal necrolysis.
    Famularo G; Di Dona B; Canzona F; Girardelli CR; Cruciani G
    Ann Pharmacother; 2007 Jun; 41(6):1083-4. PubMed ID: 17456541
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.
    Campione E; Mazzotta A; Paternò EJ; Diluvio L; Prinz JC; Chimenti S
    Acta Derm Venereol; 2009; 89(3):288-91. PubMed ID: 19479128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three significant cases of neutropenia with etanercept.
    Wenham C; Gadsby K; Deighton C
    Rheumatology (Oxford); 2008 Mar; 47(3):376-7. PubMed ID: 18180249
    [No Abstract]   [Full Text] [Related]  

  • 38. Resolution of treatment-related arthralgias and serologic findings with a switch of TNF antagonist therapies in a patient with psoriatic arthritis.
    Fischer P
    J Clin Rheumatol; 2007 Oct; 13(5):294-5. PubMed ID: 17921804
    [No Abstract]   [Full Text] [Related]  

  • 39. Facial granulomatous nodules during etanercept treatment for psoriasis.
    Samimi M; Lorette G; Machet L; de Muret A; Watier H; Maruani A
    Int J Dermatol; 2009 Sep; 48(9):1025-7. PubMed ID: 19703000
    [No Abstract]   [Full Text] [Related]  

  • 40. Do TNF-blockers reduce or induce uveitis?
    Cobo-Ibáñez T; del Carmen Ordóñez M; Muñoz-Fernández S; Madero-Prado R; Martín-Mola E
    Rheumatology (Oxford); 2008 May; 47(5):731-2. PubMed ID: 18346974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.